全文获取类型
收费全文 | 944篇 |
免费 | 24篇 |
国内免费 | 97篇 |
专业分类
耳鼻咽喉 | 3篇 |
儿科学 | 38篇 |
妇产科学 | 1篇 |
基础医学 | 47篇 |
口腔科学 | 20篇 |
临床医学 | 129篇 |
内科学 | 210篇 |
皮肤病学 | 7篇 |
神经病学 | 123篇 |
特种医学 | 123篇 |
外科学 | 85篇 |
综合类 | 37篇 |
预防医学 | 25篇 |
眼科学 | 53篇 |
药学 | 86篇 |
肿瘤学 | 78篇 |
出版年
2023年 | 4篇 |
2022年 | 1篇 |
2021年 | 11篇 |
2020年 | 3篇 |
2019年 | 10篇 |
2018年 | 10篇 |
2017年 | 8篇 |
2016年 | 8篇 |
2015年 | 4篇 |
2014年 | 12篇 |
2013年 | 29篇 |
2012年 | 27篇 |
2011年 | 26篇 |
2010年 | 42篇 |
2009年 | 34篇 |
2008年 | 35篇 |
2007年 | 89篇 |
2006年 | 59篇 |
2005年 | 42篇 |
2004年 | 40篇 |
2003年 | 29篇 |
2002年 | 31篇 |
2001年 | 31篇 |
2000年 | 26篇 |
1999年 | 33篇 |
1998年 | 43篇 |
1997年 | 42篇 |
1996年 | 30篇 |
1995年 | 34篇 |
1994年 | 28篇 |
1993年 | 42篇 |
1992年 | 10篇 |
1991年 | 14篇 |
1990年 | 18篇 |
1989年 | 31篇 |
1988年 | 25篇 |
1987年 | 16篇 |
1986年 | 17篇 |
1985年 | 14篇 |
1984年 | 11篇 |
1983年 | 4篇 |
1982年 | 8篇 |
1981年 | 4篇 |
1980年 | 11篇 |
1979年 | 2篇 |
1978年 | 6篇 |
1977年 | 8篇 |
1976年 | 1篇 |
1975年 | 2篇 |
排序方式: 共有1065条查询结果,搜索用时 15 毫秒
101.
102.
Patients with the syndrome of chronic daily headache often report migrainous symptoms and consequently are diagnosed as having a primary headache syndrome. We report two cases of idiopathic intracranial hypertension causing chronic daily headache with migrainous features in the absence of associated papilledema. 相似文献
103.
清除骨髓中癌细胞的磁性微球研究 II.聚苯乙烯磁性微球的研制 总被引:1,自引:0,他引:1
为制备能用于清除骨髓中癌细胞的磁性微球,首先合成了单分散、大粒径的多孔聚苯乙烯交联微球,借助微球多孔结构对其进行磁化。探讨了影响磁化效果的主要因素。为使其与单抗连接紧密,在微球表面聚合了一层聚丙烯醛膜,使其表面带上易与单抗反应的醛基。同时测定了所制微球的磁响应性。X-射线衍射证明磁性物质为γ-Fe2O3。 相似文献
104.
A randomized prospective comparison of oral versus intraperitoneal ofloxacin as the primary treatment of CAPD peritonitis 总被引:1,自引:0,他引:1
Ignatius KP CHENG SL LUI GX FANG PY CHAU SW CHENG Frances H CHIU TM CHAN WK LO BY CHOY CY LO 《Nephrology (Carlton, Vic.)》1997,3(6):431-435
Summary: Oral ofloxacin has been successfully used in our centres for the primary treatment of peritonitis complicating continous ambulatory peritoneal dialysis (CAPD). In view of the progressive rise in the resistance rate to ofloxacin among peritoneal bacterial isolates, a study was conducted to determine if oral ofloxacin remains a viable first line treatment for CAPD peritonitis in our centres and if the result can be improved by changing from an oral to an intraperitoneal (i.p.) route. In patients on three 2 L daily CAPD exchanges, ofloxacin given at the i.p. dosage of 200 mg loading followed by 25 mg/L of peritoneal dialysate achieved overnight trough peritoneal levels which are at least four times the minimal 90% inhibitory concentration (MIC90) of most bacterial pathogens without significant accumulation in the systemic circulation. This i.p. dosage was therefore chosen for the clinical study and the result was compared to that using ofloxacin given in the oral dosage of 400 mg loading followed by 300 mg once daily as maintenance. of all the recruited episodes, 35 were eligible for analysis. the overall primary cure rate including primary failures and relapses was 55.6% (10/18) in the oral treatment group and 70.6% (12/17) in the i.p. treatment group. the corresponding figures for gram positive bacterial (g +) infections were 36.4% and 50%, for gram negative bacterial (g -) infections were 66.7 and 80% and for culture negative infections were 75 and 80%. In culture positive cases, all treatment failures were due to resistant infections which were observed in 42.3% of all bacterial isolates, 47.1% of g + isolates and 33.3% of g - isolates. Due to the high background level of bacterial resistance among our CAPD population, ofloxacin monotherapy given either by the oral or the i.p. route can no longer be recommended for the primary treatment of CAPD peritonitis. 相似文献
105.
David G. Standaert Steven L. Galetta Robert W. Hurst John B. Chawluk 《Journal of neuroimaging》1992,2(4):208-211
The diagnosis of dural carotid-cavernous fistula is often elusive. The 2 patients described experienced the insidious onset of ocular signs and symptoms. Evaluation over several months including computed tomography and magnetic resonance imaging revealed only nonspecific abnormalities. In both patients, magnetic resonance angiography showed features characteristic of carotid-cavernous shunting, confirmed by cerebral arteriography. Magnetic resonance angiography is an important tool for the evaluation of patients with suspected dural carotidcavernous fistulas. 相似文献
106.
107.
108.
阿克拉霉素A聚氰基丙烯酸异丁酯毫微粒冻干针剂体内外抗肝癌活性 总被引:6,自引:0,他引:6
阿克拉霉素A聚氰基丙烯酸异丁酯毫微粒的冻干针剂,能明显抑制体外培养人肝癌细胞株7703的生长,IC50为0.28μg·ml-1。在0.8μg·ml-1浓度时,克隆形成抑制率为90%,抑制作用有明显剂量依赖关系而未见明显时间依赖关系。静脉给药后,对常位移植人肝癌模型裸小鼠的抑瘤率为86.84%,肿瘤细胞增殖活性阳性率为20.83%。体内外均显示明显的抗肝癌活性,且体内抗肝癌活性比阿克拉霉素A冻干针剂强。 相似文献
109.
Michele Emdin Claudio Passino Silvia Del Ry Concetta Prontera Fabio Galetta Aldo Clerico 《Clinical chemistry and laboratory medicine》2003,41(5):686-692
In order to study the influence of gender on circulating levels of cardiac natriuretic hormones (CNHs) in heart failure, we measured the plasma levels of atrial natriuretic peptide (ANP) and brain natriuretic peptide (BNP) by means of highly sensitive and specific IRMA methods in 239 consecutive patients (age 64.7 +/- 11.6 years, range 21-89 years; 170 men and 69 women) with cardiomyopathy. There was different response of CNH according to gender in patients with heart failure, as indicated by the ratio between the individual CNH values of patients and the gender-specific cut-off values. Indeed, the mean ratio for ANP found in men (3.6 +/- 3.6) was significantly higher (p = 0.0075) than that found in women (2.4 +/- 2.1). The mean ratio for BNP was on average 2.3 fold higher (15.9 +/- 27.1 in men and 6.9 +/- 6.8 in women, p = 0.0084). Moreover, age, ejection fraction, and disease severity independently and significantly contributed to regression with both ANP (R = 0.612, F = 39.969, p < 0.0001) and BNP (R = 0.656, F = 49.957, p < 0.0001) values, while gender did not. In conclusion, our study suggests a different, gender-specific activation of the CNH system in this clinical condition, although age, ejection fraction and disease severity seem to be more powerful predictors than gender of circulating levels of ANP and BNP in patients with heart failure. 相似文献
110.
目的:从细胞水平,观察扶元起萎,养荣生肌的中药制剂肌萎灵注射液对原代培养鼠胚脊髓运动神经元的保护作用。方法:实验于2004-03/2005-03在解放军第三军医大学完成。实验分组:清洁级SD雌性孕鼠,孕期10~14d。应用密度梯度离心法分离鼠胚脊髓运动神经元进行原代培养,运动神经元培养72h后,按培养板及孔分为4.5μg/L肌萎灵组(肌萎灵注射液,含生药0.9g/mL)、9μg/L肌萎灵组、45μg/L肌萎灵组、力如太组(力如太R利鲁唑片,应用时经0.9%NaCl-0.01NHCl溶解)和对照组。实验处理:各组分别加入用新鲜培养基稀释为0.5%(终浓度4.5μg/L)、1%(终浓度9μg/L)、5%(终浓度45μg/L)的肌萎灵注射液,力如太组加入利鲁唑(终浓度10μmo/L),对照组加入等量新鲜培养基。实验评估:①共同培养3d用四甲基偶氮唑盐法观察其对细胞活力的影响,以吸光度表示。②采用NF-200免疫组织化学染色并进行图像分析,测定神经突起主干长度。结果:①培养的运动神经元活力状态比较:4.5,9,45μg/L肌萎灵组培养运动神经元活力显著增强,与对照组相比,差异有显著性意义(0.317±0.054,0.396±0.087,0.329±0.097,0.230±0.130,P<0.05)。力如太组细胞生长与对照组相比无显著差异(0.266±0.141,0.230±0.130,P>0.05)。②脊髓运动神经元突起生长情况结果:4.5μg/L肌萎灵组和9μg/L肌萎灵组可促进其生长,与对照组相比,差异有显著性意义[(315.96±32.32),(373.46±80.24),(159.71±48.95)μm,P<0.05]。结论:肌萎灵注射液可增强运动神经元活力,促进脊髓运动神经元突起的生长。 相似文献